Ciclesonide: a safe and effective inhaled corticosteroid for the treatment of asthma
Open Access
- 1 February 2009
- journal article
- review article
- Published by Informa UK Limited in Journal of Asthma and Allergy
- Vol. 2, 25-32
- https://doi.org/10.2147/jaa.s4651
Abstract
Ciclesonide: a safe and effective inhaled corticosteroid for the treatment of asthma Timothy J Schaffner1,2David P Skoner1,2,31Division of Allergy, Asthma, and Immunology, Allegheny General Hospital, Pittsburgh, PA, USA; 2West Virginia University School of Medicine, Morgantown, WV, USA; 3Drexel College of Medicine, Philadelphia, PA, USA Ciclesonide is a novel inhaled corticosteroid used in the continuous treatment of mild-to-severe asthma. Its formulation and mechanism of action yield a low oral and systemic bioavailability, and high pulmonary deposition. In multiple clinical trials, ciclesonide is at least as effective as either fluticasone propionate or budesonide at symptom control, while in many cases having improved safety outcomes and tolerability. The improved safety and comparable efficacy profiles of ciclesonide demonstrated in current studies could potentially yield a treatment option that may lead to improved adherence and outcome.Keywords: ciclesonide, asthma, inhaled corticosteroidKeywords
This publication has 53 references indexed in Scilit:
- Impact of inhaled corticosteroid-induced oropharyngeal adverse events: results from a meta-analysisAnnals of Allergy, Asthma & Immunology, 2007
- A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthmaClinical Therapeutics, 2006
- Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthmaRespiratory Medicine, 2006
- In Vitro metabolism of ciclesonide in human lung and liver precision‐cut tissue slicesBiopharmaceutics & Drug Disposition, 2006
- Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthmaJournal of Allergy and Clinical Immunology, 2005
- Formation of fatty acid conjugates of ciclesonide active metabolite in the rat lung after 4-week inhalation of ciclesonidePulmonary Pharmacology & Therapeutics, 2005
- Once-daily ciclesonide 80 or 320μg for 12 weeks is safe and effective in patients with persistent asthmaRespiratory Medicine, 2005
- Effects of hydrofluoroalkane formulations of ciclesonide 400 µg once daily vs fluticasone 250 µg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthmaBritish Journal of Clinical Pharmacology, 2004
- The Burden of Asthma in the United StatesAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Surveillance for asthma--United States, 1980-1999.2002